Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
- PMID: 36810543
- PMCID: PMC9944083
- DOI: 10.3390/diseases11010029
Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
Abstract
Osteoporosis is a common disease, defined primarily by a low measured bone density, which is associated with an increased risk of fragility fractures. Low calcium intake and vitamin D deficiency seem to be positively correlated with the prevalence of osteoporosis. Although they are not suitable for the diagnosis of osteoporosis, the biochemical markers of bone turnover can be measured in serum and/or urine, enabling the assessment of the dynamic bone activity and the short-term effectiveness of the osteoporosis treatment. Calcium and vitamin D are essential for maintaining bone health. The aim of this narrative review is to summarize the effects of vitamin D and calcium supplementation separately and in combination, on bone density and circulating serum and blood plasma vitamin D, calcium, parathyroid hormone levels, markers of bone metabolism concentrations, and clinical outcomes, such as falls and osteoporotic fractures. We searched the PubMed online database to find clinical trials from the last five years (2016-April 2022). A total of 26 randomized clinical trials (RCTs) were included in this review. The present reviewed evidence suggests that vitamin D alone or in combination with calcium increases circulating 25(OH)D. Calcium with concomitant vitamin D supplementation, but not vitamin D alone, leads to an increase in BMD. In addition, most studies did not detect significant changes in circulating levels of plasma bone metabolism markers, nor in the incidence of falls. Instead, there was a decrease in blood serum PTH levels in the groups receiving vitamin D and/or Ca supplementation. The plasma vitamin D levels at the beginning of the intervention, and the dosing regimen followed, may play a role in the observed parameters. However, further study is needed to determine an appropriate dosing regimen for the treatment of osteoporosis and the role of bone metabolism markers.
Keywords: PTH; bone density; bone turnover markers; calcium; falls; fractures; osteoporosis; vitamin D.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].Nefrologia. 2008;28 Suppl 3:67-78. Nefrologia. 2008. PMID: 19018742 Spanish.
-
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.Arch Osteoporos. 2017 Dec;12(1):13. doi: 10.1007/s11657-017-0306-7. Epub 2017 Jan 26. Arch Osteoporos. 2017. PMID: 28124221 Free PMC article.
-
Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.J Bone Miner Res. 2004 Aug;19(8):1221-30. doi: 10.1359/JBMR.040511. Epub 2004 May 24. J Bone Miner Res. 2004. PMID: 15231008 Clinical Trial.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Calcium and vitamin D nutrition and bone disease of the elderly.Public Health Nutr. 2001 Apr;4(2B):547-59. doi: 10.1079/phn2001140. Public Health Nutr. 2001. PMID: 11683549 Review.
Cited by
-
Vitamin D deficiency trends, risk factors, and occupational risk in active component service members of the U.S. Armed Forces, 2018-2022.MSMR. 2024 Aug 20;31(8):2-7. MSMR. 2024. PMID: 39255511 Free PMC article.
-
Interaction between MARK3 (rs11623869), PLCB4 (rs6086746) and GEMIN2 (rs2277458) variants with bone mineral density and serum 25-hidroxivitamin D levels in Mexican Mestizo women.Front Endocrinol (Lausanne). 2024 Apr 23;15:1392063. doi: 10.3389/fendo.2024.1392063. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38715801 Free PMC article.
-
The Brain-Gut-Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects.Adv Sci (Weinh). 2024 Oct;11(38):e2307971. doi: 10.1002/advs.202307971. Epub 2024 Aug 9. Adv Sci (Weinh). 2024. PMID: 39120490 Free PMC article. Review.
-
Vitamin D Deficiency as a Risk Factor of Preeclampsia during Pregnancy.Diseases. 2023 Nov 2;11(4):158. doi: 10.3390/diseases11040158. Diseases. 2023. PMID: 37987269 Free PMC article. Review.
-
Comprehensive High-Spatial-Resolution Imaging Metabolomics Workflow for Heterogeneous Tissues.Anal Chem. 2025 May 27;97(20):10561-10569. doi: 10.1021/acs.analchem.4c05410. Epub 2025 May 12. Anal Chem. 2025. PMID: 40353393 Free PMC article.
References
-
- Ribagin S., Roeva O., Pencheva T. Generalized Net model of asymptomatic osteoporosis diagnosing; Proceedings of the 2016 IEEE 8th International Conference on Intelligent Systems (IS); Sofia, Bulgaria. 4–6 September 2016; pp. 604–608.
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous